H ealth maintenance organizations (HMOs) that employ their own staff typically are open from 9 am to 5 pm on weekdays, with an urgent care center open from 7 am to 9 pm 7 days a week. A recent study, which was supported in part by the Agency for Health Care Policy and Research (National Research Service Award T32 HS00020), found that unscheduled patient visits to the urgent care center of one such HMO were common. Although some urgent care visits occurred after regular office hours, others occurred at the same time HMO primary care physicians (PCPs) were seeing patients. Almost half of the patients (47 percent) said they were unable to get a primary care appointment and would have preferred to see their PCP within a day or two rather than going to the urgent care department.
Improvement in HMO organization and scheduling systems to facilitate same-day access to PCPs could reduce use of HMO urgent care services and increase patient satisfaction, according to the study. Anna E.
Plauth, M.D., M.P.H., and Steven D. Pearson, M.D., M.Sc., of Harvard Medical School and Harvard Pilgrim Health Care, surveyed patients 18 years of age and older for their reasons for seeking care at the urgent care department of a large, urban health center of a staff-model HMO instead of with their HMO primary care physician.
When asked why they came to the urgent care department instead of the primary care offices, 64 percent said they needed to be seen immediately, 47 percent came because the primary care offices were closed, 27 percent cited the constraints of work or childcare, and 25 percent said they were unable to get an appointment with their PCP. Only 59 percent of patients said it was easy to get an appointment with their PCP when they were sick or needed medical advice.
See "Discontinuity of care: Urgent care utilization within a health maintenance organization," by Drs. Plauth and Pearson, in the November 1998 American Journal of Managed Care 4, pp. 1531-2537. s Lack of same-day access to a primary care provider prompts many HMO patients to seek more costly urgent care
No. 224, March 1999 C ardiovascular disease (CVD) is the leading cause of death in the United States, accounting for 41 percent of all deaths. Physicians can play an important role in preventing CVD by screening, counseling, and/or suggesting medication to address the risk factors of smoking, hyperlipidemia, hypertension, obesity, and sedentary lifestyle. Yet, depending on their specialty, doctors vary dramatically in their provision of CVD prevention services, with cardiologists being the group most likely to offer them, concludes a study supported in part by the Agency for Health Care Policy and Research (HS07892 and HS09538) .
Massachusetts General Hospital researchers Randall S. Stafford, M.D., Ph.D., and David Blumenthal, M.D., M.P.P., analyzed nearly 31,000 adult visits to a national random sample of 1,521 physicians and used mathematical models to estimate the independent effects of physician and patient characteristics on CVD prevention practices. CVD prevention services offered during these visits included blood pressure measurement (50 percent of visits); cholesterol testing (5 percent); counseling for exercise (12 percent), weight (6 percent), cholesterol (4 percent), and smoking (3 percent); and treatment with antihypertensives (12 percent) and lipidlowering medications (2 percent).
Compared with general internists, cardiologists were more apt to provide CVD prevention services (odds ratio, OR, of 1.65; 1 is equal odds), while obstetricians/ gynecologists were less likely to provide these services (OR, 0.68 to 0.82), as were family physicians (OR, 0.64 to 0.74), general practitioners (0.53 to 0.63), other medical specialists (OR, 0.59 to 0.72), and surgeons (0.05 to 0.06). The researchers conclude that primary care physicians vary widely in their practices with regard to CVD prevention and call for efforts to address these practice variations.
See "Specialty differences in cardiovascular disease prevention practices," by Drs. Stafford and Blumenthal, in the Journal of the American College of Cardiology 32, pp. 1238 Cardiology 32, pp. -1243 Cardiology 32, pp. , 1998 Physicians vary widely in providing heart disease prevention services to their patients H emochromatosis is a common and treatable genetic disease characterized by excessive absorption of dietary iron. It affects 2 to 5 of every 1,000 people in the United States and may cause tissue damage and dysfunction of the liver, pancreas, heart, and pituitary gland. A gene for hemochromatosis was discovered in 1996, but many questions remain about the accuracy of genetic testing for this condition.
Interest in including screening for hemochromatosis using serum transferrin saturation testing (even without DNA test results) in the routine medical care of adults has grown in recent years. The goal of screening programs is to diagnose iron status disorders, particularly hemochromatosis, before they lead to iron overload and chronic disease states.
Two recent papers, resulting from a study supported by the Agency for Health Care Policy and Research (HS07616), examine the prevalence of hereditary hemochromatosis among primary care patients and the practical issues involved when iron status screening for hemochromatosis is implemented. The AHCPR-supported study was led by Pradyumna D. Phatak, M.D., of the University of Rochester School of Medicine and Dentistry. The two papers are summarized here. This study of 22 primary care practices in Rochester, NY, examined the prevalence of hemochromatosis among 16,031 outpatients without a previous diagnosis of the condition. The researchers screened patients with serum transferrin saturation screening tests and offered liver biopsies to confirm the diagnosis. The prevalence of clinically proven and biopsy-proven hemochromatosis combined was 4.5 per 1,000 people in the total sample and 5.4 per 1,000 in white patients. Twice as many men were diagnosed with hemochromatosis as women.
Phatak
Diagnosis of hemochromatosis is routinely followed by the screening of first-degree relatives, but routine screening for hemochromatosis in primary care is not recommended at this time. However, given the high prevalence of undiagnosed hemochromatosis among whites, these researchers recommend routine primary care screening with serum transferrin saturation testing in this population. They point out that the degree of iron overload in many of these patients suggested that irreversible damage would have occurred if the disease had gone unrecognized and tissue iron stores had continued to accumulate. The percentage of patients who developed complications while receiving heparin was small, but obviously, it should be used selectively and carefully to avoid over-anticoagulation, according to these researchers. The risk of gastrointestinal hemorrhage during short-term heparin administration for acute stroke patients appears to be considerably greater than for similar patients receiving long-term treatment with warfarin and aspirin. This could be due to a number of factors, including the ease with which patients may be accidentally over-treated with intravenously administered heparin and a possible propensity for stress-related hemorrhagic gastroduodenal ulceration or gastritis in the setting of acute stroke, particularly stroke causing severe neurologic deficits.
McDonnell
For both aspirin and warfarin, most complications occurred within the first year of treatment. Patients who had complications from warfarin therapy were generally older at the time of their initial stroke-related event than patients who did not have complications.
See to examine the factors contributing to low birthweight, particularly among lowincome black women who are at increased risk for delivering low birthweight babies. In addition, PORT researchers studied practices aimed at preventing low birthweight and its major sequelae. Led by Robert L. Goldenberg, M.D., of the University of Alabama at Birmingham, the researchers recently published three studies, as well as the PORT final report. All are summarized here.
The first study demonstrates success with a five-step approach to increase doctors' use of corticosteroids, which are known to improve outcomes in preterm babies. The second study recommends that the routine screening of pregnant women for thrombocytopenia be discontinued. The third study concludes that maternal serum levels of metalloproteinase-9 do not appear to predict spontaneous preterm birth. A multipart intervention to improve the quality of care that physicians give to pregnant women has been successful and shows promise of decreasing infant mortality and disability in preterm infants. The goal of the intervention was to increase the appropriate use of corticosteroids, which when given prior to a preterm birth can reduce the risk of complications. According to Dr. Goldenberg and colleagues, this intervention resulted in a 33 percent increase in the use of corticosteroids.
The study focused on minority and other high-risk women who tend to deliver preterm babies because of poor pregnancy weight gain, low prepregnancy weight, and other related lifestyle issues. Corticosteroid use is known to be one of the most effective ways to improve the outcomes of babies born preterm and reduce infant mortality and disability in preterm babies. These findings suggest that knee surgery should not be expanded to small hospitals; instead it should be centralized at regional centers where at least 50-and preferably 100-operations each year are assured. This is one way to reduce in-hospital complications, according to the PORT researchers. They analyzed 6 years of Medicare claims data and other data files for patients who underwent primary knee replacement from 1985 to 1990. Models were used to estimate the probability that a patient would have an in-hospital complication. The models controlled for hospital volume, other hospital characteristics, patient demographics, and patient health status. A panel of two orthopedic surgeons and two internists reviewed diagnosis codes to determine whether a complication was likely, possible, or due to anemia.
The researchers calculated that increasing the number of annual hospital knee replacement operations from 40 to 80 would decrease the probability of a likely complication for Medicare patients by about 3 percent. Including younger patients would increase the thresholds for total volume to 53 and 107. The most likely complications were disorders of fluid, electrolyte, and acid-base balance; cardiac dysrhythmias; complications affecting specified body systems; and rupture of a tendon.
For more details, see "The effect of hospital volume on the in-hospital complication rate in knee The AHCPR Low Birthweight PORT researchers used a five-step intervention to increase doctors' use of corticosteroids. The quality improvement program included enlisting local medical opinion leaders to encourage doctors to administer corticosteroids, lectures for doctors on corticosteroids, reminders in medical charts to use them, regular discussions with doctors on the various preterm scenarios, and ongoing feedback on their use of corticosteroids.
Although a National Institutes of Health Consensus Conference and several medical societies have endorsed the use of corticosteroids to reduce the complications of preterm delivery, this treatment continues to be underused by the medical community. According to the researchers, the reasons for this low use include the fact that many obstetricians underestimate the benefits of corticosteroids, and hospital obstetrical practices for preterm labor do not always allow for the most optimal timing of corticosteroid administration. Routine screening of pregnant women for thrombocytopenia-or a low blood platelet count-a cause of bleeding disorders, should be discontinued. This practice fails to meet established pregnancy screening criteria. Also, it may actually be harmful because it may place unaffected fetuses of thrombocytopenic women and the women themselves at risk from invasive procedures. The researchers reviewed the literature to determine the potential for maternal thrombocytopenia screening to detect fetal thrombocytopenia and prevent fetal or neonatal mortality.
Rouse
Autoimmune thrombocytopenia occurs in about 2 in 1,000 pregnancies and is estimated to result in neonatal intracranial hemorrhage in about 2 in 100,000 births. Gestational thrombocytopenia, which occurs in 4 percent to 7 percent of pregnancies, is 40 to 70 times as prevalent in pregnancy as the autoimmune form, but it poses negligible risk to the fetus. What's more, maternal thrombocytopenia has been shown to be a relatively insensitive indicator of severe fetal thrombocytopenia. The positive predictive value of such a screening test, that is, its ability to predict an infant who will sustain an intracranial hemorrhage based on identifying mothers with the condition, is 0.1 percent, calculate the researchers.
A maternal history of nongestational thrombocytopenia should identify nearly all of the about 2 in 1,000 women at presumed risk of delivering a severely thrombocytopenic infant. Also, women with gestational thrombocytopenia, which carries no risk to the fetus, may be diagnosed with autoimmune thrombocytopenia, and subjected needlessly to invasive diagnostic and therapeutic interventions such as cordocentesis and cesarean delivery. This screening test has an unacceptably high falsepositive rate and is insensitive, that is, it fails to identify many at-risk fetuses, conclude the researchers.
Tu, F.F., Goldenberg, R.L., Tamura, T., and others. (1998). "Prenatal plasma matrix metalloproteinase-9 levels to predict spontaneous preterm birth." Obstetrics and Gynecology 92, pp. 446-449.
The ability to identify biomarkers that can predict the onset of preterm labor or premature rupture of membranes would be invaluable in designing a therapy to prevent these problems. The Low Birthweight PORT was hopeful that a zincdependent proteinase, plasma matrix metalloproteinase-9, might be such a marker. However, this study shows that although levels of this substance remain unchanged throughout pregnancy and then rise three-fold at the onset of spontaneous labor, levels obtained just prior to delivery do not appear to predict spontaneous preterm birth.
The research team used an enzyme-linked immunosorbent assay to measure matrix metalloproteinase-9 levels in plasma samples from 35 nonpregnant women and in stored plasma samples obtained during a randomized trial of zinc supplementation in pregnant women. They then periodically sampled plasma levels of women who eventually delivered following spontaneous labor or premature rupture of membranes at 24 to 32 weeks, 33 to 36 weeks, and greater than 37 weeks.
They found that plasma matrix metalloproteinase-9 levels averaged about 19 ng/mL from 19 weeks until 36 weeks and did not change significantly as the gestational age increased. This remained true regardless of whether women ultimately delivered at 24 to 32, 33 to 36, or after 37 weeks. Levels obtained prior to, but within 1 week of, presentation for delivery were not significantly different from those obtained earlier in pregnancy. Finally, levels for women in spontaneous labor were similar regardless of gestational age and were increased three-fold compared with those drawn at each prenatal visit. Black men are almost twice as likely as white men to be initially diagnosed with advanced-stage prostate cancer. But it is their higher level of illiteracy, not black race, that seems to be a barrier to early cancer diagnosis, according to the authors of this study. Low-income black men are probably not aware of the need to undergo prostate cancer screening nor of the availability of screening at churches, schools, clinics, and hospitals, explain the researchers. They evaluated literacy and prostate cancer stage at diagnosis in 212 lowincome men who received medical care at equal-access sites in two different cities. The researchers developed a model to evaluate predictors of metastatic prostate cancer at presentation as a function of patient age, race, literacy, and city.
Low Birthweight in Minority and
Half of black men were diagnosed with advanced-stage disease compared with 36 percent of white men. Also, black men were nearly six times more likely to have literacy levels less than sixth grade (52 percent vs. 9 percent). Men with metastatic cancer at diagnosis were 1.5 times more likely to have lower literacy levels (less than sixth grade for 40 percent with stage D vs. 25 percent for stages A to C). After adjustment for differences in literacy, age, and city, race was not a significant predictor of advancedstage prostate cancer.
Illiterate blacks may lack adequate knowledge of prostate cancer screening and early detection efforts, many of which are highlighted in written media or presented in materials that are often written at a literacy level above that of a significant portion of the American population. The researchers conclude that culturally sensitive, low-literacy educational materials developed in collaboration with the target population may improve patient awareness of prostate cancer and decrease racial variations in stage of prostate cancer at diagnosis. This study demonstrates that men whose prostate biopsy specimens show Gleason score 2 to 4 disease (low-grade or highly differentiated tumor) face a minimal risk of death from prostate cancer within 15 years of diagnosis. Conversely, men whose biopsy specimens show Gleason score 7 to 10 disease (high-grade or poorly differentiated tumor) face a high risk of death from prostate cancer when treated conservatively, even when cancer is diagnosed as late as age 74. Men with Gleason score 5 or 6 disease face a modest risk of death from prostate cancer that increases slowly over at least 15 years of followup.
Albertsen
These findings are based on risk analysis of 767 men (aged 55 to 74 years at diagnosis) with localized prostate cancer diagnosed between 1971 and 1984, either not treated or treated with immediate or delayed hormonal therapy. They were followed for 10 to 20 years after diagnosis. Based on data gathered from patients' medical charts, the researchers estimated the probability of dying from prostate cancer or other causes given the patients' tumor histology and age at diagnosis.
The risk of dying from prostate cancer within 15 years (depending on their age at diagnosis) was 4 to 7 percent for men whose tumors had Gleason scores of 2 to 4, 6 to 11 percent for a score of 5, 18 to 30 percent for a score of 6, 42 to 70 percent for a score of 7, and 60 to 87 percent for a score of 8 to 10. A majority of the younger men in this study with Gleason 2 to 4 tumors are still alive but face a possibility of death from prostate cancer in the future. In contrast, most older men with Gleason 2 to 4 tumors have died from other medical causes rather than prostate cancer. Men with tumors with Gleason scores 7 to 10 experienced a very high rate of death from prostate cancer regardless of their age at diagnosis. Very few of these men of any age were alive 15 years later, with most dying from prostate cancer. Half of younger men visiting primary care physicians (PCPs) experience bothersome genitourinary (GU) symptoms. One-fourth of these men worry that their GU symptoms may be related to prostate cancer, according to this study. This finding alone supports the need for PCPs to address the issue of GU symptoms with their younger male patients to educate them about prostate cancer, recommend the researchers.
Collins

continued on page 10
Prostate cancer continued from page 9
They gave a self-administered survey to 101 men (mean age of 36 years) visiting a primary care group practice. The survey included the American Urological Association Symptom Index, a benign prostatic hyperplasia (BPH) impact index, as well as additional questions about GU pain, sexual dysfunction, and history of GU diseases. The researchers then reviewed the medical records of men with GU symptoms.
Half of these men reported GU symptoms, 27 percent of all men reported a history of at least one GU disease, and 17 percent had more than one; 16 percent of men had been to a urologist. Ninety percent of all men thought that PCPs should routinely ask younger men GU questions as part of their general health care. s
Home Health Care
I n order for people using home health services to remain alone in their homes without family or other informal support, they often need nutritional support, help with household chores, and/or other formal services to supplement medical and nursing care. These services may be the key that enables a person to use home care rather than institutional care. Yet nearly half of home health care clients receive only some or none of the support services they need, according to a study supported in part by the Agency for Health Care Policy and Research (HS06843).
Typically, support services are not provided because they are not reimbursable, the demand for some services outweighs supply, physicians writing home care orders are not aware of all their patients' needs, and/or hospital discharge planners have not arranged for the correct mix of support services. Certain patient factors decrease the likelihood that adequate care will be provided. These include being black or a member of another minority group, having Medicaid insurance, being in a health maintenance organization, having AIDS, and receiving maternal/child health services.
Cindy Parks Thomas, P.A., M.S., of Brandeis University, and Susan M. Payne, Ph.D., of Case Western Reserve University, collected data from 2,013 home health clients of 12 nonprofit agencies in Massachusetts in 1993 to examine client-related factors associated with the need for formal support services and factors associated with whether those needs were adequately met. They asked the visiting nurse to identify unmet need for support services. Overall, 85 percent of clients needed one or more support services. Nearly half of the home health clients were not receiving enough support to meet all of their needs. Of those with any unmet need, over 80 percent needed three or more services that were not being provided. If the home health visit was a hospital admission visit or the patient had an acute condition, the need for support services was less likely to be met than if the patient was an ongoing client.The services with the highest level of unmet need were mental health, with 56 percent not receiving needed services, social work (45 percent), and speech therapy (51 percent).
Details are in "Home alone: Unmet need for formal support services among home health clients," by Ms. Thomas According to Cynthia D. Mulrow, M.D., M.Sc., the study's lead investigator and a professor of medicine and geriatrics at the University of Texas Health Science Center at San Antonio, SSRIs are therapies of choice for many practitioners, but there are a lot of treatment options, and no particular class of drugs is routinely more effective than others. The EPC found that both newer and older generation antidepressants have side effects. Patients taking the newer antidepressants were more likely to have higher rates of diarrhea, nausea, insomnia, and headache. The older drugs were likely to cause adverse effects on the heart and blood pressure and result in dry mouth, constipation, dizziness, blurred vision, and/or tremors. Although anecdotal reports suggest high rates of difficulty in sexual functioning, this study found few data that directly address this problem.
The study did not compare drug costs for the nine categories of
Pediatric HIV
Continued from page 11 percent, respectively, warranted prophylaxis for PCP but did not receive it. Consensus groups now recommend simultaneous prophylaxis of HIV-infected children with both nucleoside analogs and protease inhibitors, which will further increase prescription costs. While not burdensome to the U.S. health care system as a whole (prescription costs for these children were less than one-tenth of 1 percent of the $71 billion spent on medications in 1992), for selected payers such as Medicaid, these additional costs could compound the effects of medical inflation and HIV's increasing prevalence.
More details are in "Medications used for paediatric HIV infection in the USA, 1991 USA, -1992 Acute sinusitis is one of the most common primary care problems in the United States. Millions of cases occur each year, affecting all age groups and all segments of the general population. Although not all people who contract the condition seek treatment from a physician, most still incur costs in buying overthe-counter medications and time lost from work. In 1992, Americans spent $200 million on prescription cold medications and more than $2 billion for over-the-counter medications.
Even though sinusitis is so common, its management is challenging. In most cases, the condition involves inflammation of both the sinuses (sinusitis) and nasal passages (rhinitis), but the causes vary. If the sinusitis is not caused by bacteria, treatment with antibiotics will have limited or no effect and may have adverse side effects. However, because patients with bacterial sinusitis may develop a more serious sinus infection, it is important to properly diagnose and treat these patients. The Center's report focuses on the diagnosis and treatment of uncomplicated, community-acquired, acute bacterial sinusitis in children and adults.
As noted by Joseph Lau, M.D., Director of the New England Medical Center EPC, the research shows that using x-rays or other diagnostic procedures is not a costeffective initial strategy for uncomplicated patients. He calls for additional research to determine the best ways to screen patients for infections.
In addition, the study concluded that:
• More patients were cured, and cured earlier, when treated with antibiotics rather than placebo; however, about two-thirds of patients receiving placebos recovered without antibiotics. The USPSTF, an independent panel of preventive health experts, was first convened in 1984 by the U.S. Public Health Service. It is charged with evaluating the scientific evidence for the effectiveness of a range of clinical preventive services, including common screening tests, immunizations, and counseling for health behavior change and to produce age-and risk-factor-specific recommendations for these services. The Task Force published its first set of recommendations in the 1989 Guide to Clinical Preventive Services; the Guide was revised in 1995. The third USPSTF was convened in November 1998. These initial 12 topics were selected by the Task Force members based on preliminary work by AHCPR's two clinical prevention centers: the Research Triangle Institute and University of North Carolina at Chapel Hill (UNC) and Oregon Health Sciences University (OHSU). The selection process included a preliminary literature search of new information on prevention and screening published since 1995; consultation with professional societies, health care organizations, and outside prevention experts; a review of current levels of controversy and variation in practice; and consideration of the potential for a change from current USPSTF recommendations. Additional topics for new assessments and updates will be selected and announced periodically over the next 2 years. The new topics are:
• Chemoprophylaxis (for example, tamoxifen and related drugs) to prevent breast cancer.
• Vitamin supplementation to prevent cancer or coronary heart disease (vitamin E, folate, beta carotene, and vitamin C).
• Screening for bacterial vaginosis in pregnancy.
• Developmental screening in children. The topics to be updated are: • Screening for diabetes mellitus.
• Newborn hearing screening.
• Screening for skin cancer.
• Counseling to prevent unintended pregnancy.
• Screening for high cholesterol.
• Postmenopausal hormone therapy.
• Screening for chlamydial infection.
• Screening for depression.
Nominations of new topics for consideration by the USPSTF may be sent to David Atkins, M.D., M.P.H., Coordinator for Clinical Preventive Services, Center for Practice and Technology Assessment, Agency for Health Care Policy and Research, 6010 Executive Boulevard, Room 300, Rockville, MD 20852. Priority will be given to preventive interventions that can be delivered in the primary care setting, are widely available, and for which scientific evidence exists to assess efficacy and effectiveness.
All the topics selected for evaluation by the USPSTF will be subject to rigorous analysis and research with a goal of translating the best available science into the best medical practice. To speed implementation of new and updated USPSTF recommendations, individual reports will be released as they are completed.
For more information on the USPSTF, contact Barbara Gordon at 301-594-4024. The full report of the Guide to Clinical Preventive Services, Second Edition, and highlights of the Guide are available on AHCPR's Web site at http://www.ahcpr.gov (click on "Clinical Information"). Copies of the Guide are available for purchase ($20) from AHCPR's Clearinghouse. See the back cover of Research Activities for ordering information.* s AHCPR announces new topics for the U.S. Preventive Services Task Force D id you know that you can "self-assign" your investigator-initiated research grant application to the initial review group or study section that you believe is best suited to review your application? To do this, you need to include a cover letter detailing your request with your application. Such a request generally determines where the application will be assigned for review. Self-assignment is possible for new, amended, and competing continuation applications submitted on the PHS 398 form to the Center for Scientific Review at the National Institutes of Health, where AHCPR research grant applications are received.
In your cover letter, you also may request funding consideration at either the Agency for Health Care Policy and Research or at a particular NIH component. Even if you are requesting assignment to an NIH Institute, you still may ask that your application be reviewed by an AHCPR study section if you believe that is where the most appropriate review expertise is to be found.
When you self-assign your application to AHCPR, you may choose one of the following four AHCPR study sections: Health Care Quality and Effectiveness Research (HQER), Health Research Dissemination and Implementation (HRDI), Health Systems Research (HSR), or Health Care Technology and Decision Sciences (HTDS).
AHCPR recently added a fifth study section to evaluate research training applications. However, you cannot self-assign to this study section since assignments are made only in response to specific research training program initiatives.
For more information about these study sections, see the peer review update below. For more complete information, visit AHCPR's Web site at http://www.ahcpr.gov and click on "funding opportunities" for current study section descriptions and rosters. Please direct any questions or comments about the self-assignment process to Pat Thompson, Ph.D., AHCPR's referral officer, at 301-594-1404. s 
Research grant applicants may "self-assign" to review groups
Announcements
R esearchers now have access to a powerful new data set that provides an in-depth picture of the use, quality, and costs of hospital inpatient care in the United States. This data set, which is available from the Agency for Health Care Policy and Research, includes detailed information on topics such as diagnoses, patient demographics, medical and surgical procedures, diagnostic tests, hospital charges, payment sources, and hospital characteristics.
The 1996 data set-the Nationwide Inpatient Sample (NIS)-is a one-of-a-kind database of hospital discharge information from approximately 6.5 million inpatient stays at over 900 hospitals in 19 States across the country. The NIS is the only publicly available database to include payer information, permitting analyses of care covered by private insurance, Medicare, Medicaid, and other sources.
The database is a product of the Healthcare Cost and Utilization Project, a Federal-State-industry partnership sponsored by AHCPR to produce standardized, highquality data for use in measuring and evaluating the impact of changes in the health care system on access to services, quality, outcomes, and costs. For researchers and others who want to analyze trends, NIS data sets are available for 1988 through 1996.
The data set contains more than 100 clinical and nonclinical variables, including primary and secondary diagnoses and procedures; patient demographic characteristics such as sex, race, median income, and zip code; payment source; length of stay; total charges; and admission and discharge status. The large amount of data contained in the NIS permits analysis of rare conditions, such as congenital anomalies, and studies of infrequent procedures, such as organ transplantation. The database fills a special niche in that it also includes information on care provided to the uninsured. The data set can be run on desktop computers and comes in ASCII format for ease of use with numerous off-the-shelf software products, including SAS and SPSS. NIS also includes weights for producing national and regional estimates and comes with full documentation in Adobe Acrobat. SAS and SPSS users are provided with programs for converting ASCII files.
The NIS Release 5 for 1996 is available on CD-ROM with accompanying documentation for $160 from the National Technical Information Service. The NTIS accession number is PB99-500480. The cost may be higher for customers outside the United States, Canada, and Mexico. Data from earlier NIS releases (1988 through 1995) 
New MEPS chartbook presents data on minority health
Would you like to receive AHCPR press releases and other announcements electronically? If so, we invite you to subscribe to our new general listserv. All you need is a computer and an e-mail address. Signing up is easyhere's how: 1. Send an e-mail message to listserv@list.ahcpr.gov 2. Leave the subject line blank.
3. In the body of the message type: sub public_list-L John Doe (insert your full name). 4. You will receive a return message confirming that you are now an AHCPR listserv subscriber. For the most part, the inventory is made up of final reports from AHCPR-sponsored grants and contracts, as well as some data products. It includes more than 3,000 products produced over a 30-year span by AHCPR and its predecessor agency, the National Center for Health Services Research and Health Care Technology Assessment (NCHSR). As such, it represents an archives of the health services research funded by AHCPR and NCHSR, and it can be used as a tool for mining the research findings that have been generated by the agency.
Basic information is included in each record, such as title, authors/principal investigators, and abstract. There are currently four options for searching the database: full-text, keyword, author, and product number. The keyword phrases provided are those that were assigned to the project by the project officer at the time the report or other product was submitted to NTIS.
Each item contained in the inventory is available for purchase from NTIS. You may order items directly from the system's online "shopping cart," and your order will be processed electronically.
We The objectives of this project were to (1) facilitate research on improving health and quality of life outcomes for minority populations; (2) assist and encourage minority investigators to conduct medical treatment effectiveness research relevant to minority populations; (3) provide technical assistance to others conducting treatment effectiveness research relevant to minority populations; and (4) involve the community in the center's activities. Patients studied were drawn from either the Henry Ford Health System (HFHS) or the surrounding community. Studies conducted by the center helped to separate treatment effects related to socioeconomic status and race. In 1993, over 390,000 patients of diverse socioeconomic status visited HFHS; 26.7 percent were black, and 42.1 percent of the black patients were members of a health maintenance organization (HMO). The center analyzed existing HFHS data and conducted pilot studies for effectiveness trials. The tertiary care component of HFHS provided indepth data on rare conditions (e.g., diabetes-related amputations, hospitalization for asthma). Within an HMO/community setting, differences were found in the outcomes of white and black patients being treated for asthma or diabetes; Using data from the 1994 National Survey of Women's Health Centers, this research examined the association between ownership type and the behavior of centers in terms of community benefits and management practices. The researchers compared 296 nonprofit and 108 for-profit centers. Overall, nonprofit centers provided more community benefits than for-profit centers. The nonprofit centers served more uninsured women, provided more clients with reduced rates, located more often in rural areas, and were more likely to train health professionals and to provide education services at no cost to clients. Community participation in center governance was more evident at nonprofit centers. Nonprofit primary care and reproductive health centers provided a broader range of primary care services than their forprofit counterparts. Nonprofit and for-profit centers appeared equally likely to serve women on Medicaid and minority women and to provide transportation and translator services. The analysis of management practices showed that nonprofit and for-profit centers performed similarly in terms of the utilization of clinician resources and marketing and planning. The forprofit centers, however, were more involved in managed care contracting. (Abstract and executive summary of dissertation, NTIS accession no. PB99-128340; 14 pp, $23.00 paper, $12.00 microfiche)*** The goals of this study were to (1) describe the patterns of referral from primary to specialty care for people with newly diagnosed diabetes, including the likelihood of referral, the pathways to specialty care, the duration of referral, and the types of specialists seen; and (2) evaluate the influence of patient and provider factors and the medical care system on the likelihood of referral and referral duration. A cohort of 4,577 patients with new-onset diabetes diagnosed in 1994 was identified using the physician claims database of the Alberta Health Care Insurance Plan; all claims were examined for 18 months following diagnosis. The results show that referral is relatively common, with 43 percent of diabetics receiving specialist care following their initial diagnosis. Although referral from a primary care provider was the most common route to specialty care (66 percent), referral from other specialists (20 percent), and patient self-referral (14 percent) were also important routes. Patients made an average of three visits to specialists; half had multiple referral episodes extending beyond a 2-week interval. Case-mix (diabetesrelated morbidity and other comorbidities) was the strongest predictor of referral. Younger insulin-dependent diabetics (less than age 60) were much more likely than older patients to be referred. Other significant factors included poverty, geographic access to specialist care, and the sex and experience of the generalist. This article by the leader of the Back Pain Patient Outcomes Research Team points out that outcomes research focuses on the end results of patient care in terms of symptoms, disability, and survival rather than physiology, laboratory results, or imaging. Effectiveness in routine care is a function of efficacy but also of diagnostic accuracy, physician skill in applying a treatment, patient compliance, and perhaps other factors that are artificially optimized in the clinical trial setting. Dr. Deyo uses the case of treating low back pain to discuss how a physician might evaluate whether following guidelines on a particular condition actually improved patient outcomes such as quality of life and mortality. He points out that in the case of back pain symptoms, function and quality of life can be quantified in a continued on page 22
Patterns of Referral for
